Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection
- PMID: 30626099
- PMCID: PMC6466205
- DOI: 10.3390/vaccines7010007
Utility of the Neonatal Calf Model for Testing Vaccines and Intervention Strategies for Use against Human RSV Infection
Abstract
Respiratory syncytial virus (RSV) is a significant cause of pediatric respiratory tract infections. It is estimated that two-thirds of infants are infected with RSV during the first year of life and it is one of the leading causes of death in this age group worldwide. Similarly, bovine RSV is a primary viral pathogen in cases of pneumonia in young calves and plays a significant role in bovine respiratory disease complex. Importantly, naturally occurring infection of calves with bovine RSV shares many features in common with human RSV infection. Herein, we update our current understanding of RSV infection in cattle, with particular focus on similarities between the calf and human infection, and the recent reports in which the neonatal calf has been employed for the development and testing of vaccines and therapeutics which may be applied to hRSV infection in humans.
Keywords: RSV; calf model; human; therapeutics; vaccines.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures


Similar articles
-
Neonatal calf infection with respiratory syncytial virus: drawing parallels to the disease in human infants.Viruses. 2012 Dec;4(12):3731-53. doi: 10.3390/v4123731. Viruses. 2012. PMID: 23342375 Free PMC article. Review.
-
Efficacy of mucosal polyanhydride nanovaccine against respiratory syncytial virus infection in the neonatal calf.Sci Rep. 2018 Feb 14;8(1):3021. doi: 10.1038/s41598-018-21292-2. Sci Rep. 2018. PMID: 29445124 Free PMC article.
-
Bovine Gamma Delta T Cells Contribute to Exacerbated IL-17 Production in Response to Co-Infection with Bovine RSV and Mannheimia haemolytica.PLoS One. 2016 Mar 4;11(3):e0151083. doi: 10.1371/journal.pone.0151083. eCollection 2016. PLoS One. 2016. PMID: 26942409 Free PMC article.
-
Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.Vaccine. 2007 Jun 15;25(25):4818-27. doi: 10.1016/j.vaccine.2007.04.002. Epub 2007 Apr 20. Vaccine. 2007. PMID: 17499893
-
γδ T cells and the immune response to respiratory syncytial virus infection.Vet Immunol Immunopathol. 2016 Nov 15;181:24-29. doi: 10.1016/j.vetimm.2016.02.012. Epub 2016 Feb 21. Vet Immunol Immunopathol. 2016. PMID: 26923879 Review.
Cited by
-
A Single Shot Pre-fusion-Stabilized Bovine RSV F Vaccine is Safe and Effective in Newborn Calves with Maternally Derived Antibodies.Vaccines (Basel). 2020 May 18;8(2):231. doi: 10.3390/vaccines8020231. Vaccines (Basel). 2020. PMID: 32443437 Free PMC article.
-
Interactions Between Bovine Respiratory Syncytial Virus and Cattle: Aspects of Pathogenesis and Immunity.Viruses. 2024 Nov 8;16(11):1753. doi: 10.3390/v16111753. Viruses. 2024. PMID: 39599867 Free PMC article. Review.
-
Immunization with a mucosal, post-fusion F/G protein-based polyanhydride nanovaccine protects neonatal calves against BRSV infection.Front Immunol. 2023 Jun 9;14:1186184. doi: 10.3389/fimmu.2023.1186184. eCollection 2023. Front Immunol. 2023. PMID: 37359514 Free PMC article.
-
A Recombinant BCG Vaccine Is Safe and Immunogenic in Neonatal Calves and Reduces the Clinical Disease Caused by the Respiratory Syncytial Virus.Front Immunol. 2021 Apr 26;12:664212. doi: 10.3389/fimmu.2021.664212. eCollection 2021. Front Immunol. 2021. PMID: 33981309 Free PMC article.
-
Vitamin A deficiency impairs the immune response to intranasal vaccination and RSV infection in neonatal calves.Sci Rep. 2019 Oct 22;9(1):15157. doi: 10.1038/s41598-019-51684-x. Sci Rep. 2019. PMID: 31641172 Free PMC article.
References
-
- Lozano R., Naghavi M., Foreman K., Lim S., Shibuya K., Aboyans V., Abraham J., Adair T., Aggarwal R., Ahn S.Y., et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–2128. doi: 10.1016/S0140-6736(12)61728-0. - DOI - PMC - PubMed
-
- Nair H., Nokes D.J., Gessner B.D., Dherani M., Madhi S.A., Singleton R.J., O’Brien K.L., Roca A., Wright P.F., Bruce N., et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: A systematic review and meta-analysis. Lancet. 2010;375:1545–1555. doi: 10.1016/S0140-6736(10)60206-1. - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources